BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

158 related articles for article (PubMed ID: 24424140)

  • 1. The impact of prophylactic total gastrectomy on health-related quality of life: a prospective cohort study.
    Worster E; Liu X; Richardson S; Hardwick RH; Dwerryhouse S; Caldas C; Fitzgerald RC
    Ann Surg; 2014 Jul; 260(1):87-93. PubMed ID: 24424140
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Prophylactic Total Gastrectomy: a Prospective Cohort Study of Long-Term Impact on Quality of Life.
    Muir J; Aronson M; Esplen MJ; Pollett A; Swallow CJ
    J Gastrointest Surg; 2016 Dec; 20(12):1950-1958. PubMed ID: 27752808
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Laparoscopic Prophylactic Total Gastrectomy for Hereditary Diffuse Gastric Cancer in
    Ithurralde-Argerich J; Rosner L; Rizzolo M; Faerberg A; Puma R; Ferro D; Duque C; Kujaruk M; Cuenca-Abente F
    J Laparoendosc Adv Surg Tech A; 2021 Jul; 31(7):729-737. PubMed ID: 34097461
    [No Abstract]   [Full Text] [Related]  

  • 4. The Psychosocial Impact of Undergoing Prophylactic Total Gastrectomy (PTG) to Manage the Risk of Hereditary Diffuse Gastric Cancer (HDGC).
    Hallowell N; Lawton J; Badger S; Richardson S; Hardwick RH; Caldas C; Fitzgerald RC
    J Genet Couns; 2017 Aug; 26(4):752-762. PubMed ID: 27837291
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Barriers and facilitators to CDH1 carriers contemplating or undergoing prophylactic total gastrectomy.
    McGarragle KM; Hart TL; Swallow C; Brar S; Govindarajan A; Cohen Z; Aronson M
    Fam Cancer; 2021 Apr; 20(2):157-169. PubMed ID: 32754788
    [TBL] [Abstract][Full Text] [Related]  

  • 6. An investigation of the factors effecting high-risk individuals' decision-making about prophylactic total gastrectomy and surveillance for hereditary diffuse gastric cancer (HDGC).
    Hallowell N; Badger S; Richardson S; Caldas C; Hardwick RH; Fitzgerald RC; Lawton J
    Fam Cancer; 2016 Oct; 15(4):665-76. PubMed ID: 27256430
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Prophylactic total gastrectomy (PTG) for hereditary diffuse gastric cancer (HDGC): the Newfoundland experience with 23 patients.
    Hebbard PC; Macmillan A; Huntsman D; Kaurah P; Carneiro F; Wen X; Kwan A; Boone D; Bursey F; Green J; Fernandez B; Fontaine D; Wirtzfeld DA
    Ann Surg Oncol; 2009 Jul; 16(7):1890-5. PubMed ID: 19408054
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Comparison of postoperative mid-term and long-term quality of life between Billroth-I gastroduodenostomy and Billroth-II gastrojejunostomy after radical distal gastrectomy in patients with gastric cancer: a cohort study based on a case registry database].
    Tang KN; Chen XL; Zhang WH; Yang K; Liu K; Jiang W; Chen XZ; Hu JK
    Zhonghua Wei Chang Wai Ke Za Zhi; 2022 May; 25(5):401-411. PubMed ID: 35599395
    [No Abstract]   [Full Text] [Related]  

  • 9. Optimal Timing of Total Gastrectomy to Prevent Diffuse Gastric Cancer in Individuals With Pathogenic Variants in CDH1.
    Laszkowska M; Silver ER; Schrope B; Kastrinos F; Wang TC; Hur C
    Clin Gastroenterol Hepatol; 2020 Apr; 18(4):822-829.e4. PubMed ID: 31220641
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Hereditary diffuse gastric cancer: cancer risk and the personal cost of preventive surgery.
    Kaurah P; Talhouk A; MacMillan A; Lewis I; Chelcun-Schreiber K; Yoon SS; Huntsman D
    Fam Cancer; 2019 Oct; 18(4):429-438. PubMed ID: 31273560
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Long-term quality of life and nutrition status of the aboral pouch reconstruction after total gastrectomy for gastric cancer: a prospective multicenter observational study (CCOG1505).
    Tanaka C; Kanda M; Murotani K; Yoshikawa T; Cho H; Ito Y; Matsui T; Nakayama H; Yamada T; Kobayashi D; Fujiwara M; Kodera Y
    Gastric Cancer; 2019 May; 22(3):607-616. PubMed ID: 30382468
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Therapeutic and prophylactic gastrectomy in a family with hereditary diffuse gastric cancer secondary to a CDH1 mutation: a case series.
    Gjyshi O; Vashi P; Seewald L; Kohan M; Abboud E; Fowler E; Suppiah R; Halabi H
    World J Surg Oncol; 2018 Jul; 16(1):143. PubMed ID: 30007404
    [TBL] [Abstract][Full Text] [Related]  

  • 13. International Delphi consensus guidelines for follow-up after prophylactic total gastrectomy: the Life after Prophylactic Total Gastrectomy (LAP-TG) study.
    Roberts G; Benusiglio PR; Bisseling T; Coit D; Davis JL; Grimes S; Guise TA; Hardwick R; Harris K; Mansfield PF; Rossaak J; Schreiber KC; Stanich PP; Strong VE; Kaurah P;
    Gastric Cancer; 2022 Nov; 25(6):1094-1104. PubMed ID: 35831514
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Chronological Changes of Quality of Life in Long-Term Survivors after Gastrectomy for Gastric Cancer.
    Yu W; Park KB; Chung HY; Kwon OK; Lee SS
    Cancer Res Treat; 2016 Jul; 48(3):1030-6. PubMed ID: 27004956
    [TBL] [Abstract][Full Text] [Related]  

  • 15. A prospective study of total gastrectomy for CDH1-positive hereditary diffuse gastric cancer.
    Chen Y; Kingham K; Ford JM; Rosing J; Van Dam J; Jeffrey RB; Longacre TA; Chun N; Kurian A; Norton JA
    Ann Surg Oncol; 2011 Sep; 18(9):2594-8. PubMed ID: 21424370
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Quality of life beyond the early postoperative period after laparoscopy-assisted distal gastrectomy: the level of patient expectation as the essence of quality of life.
    Lee SS; Ryu SW; Kim IH; Sohn SS
    Gastric Cancer; 2012 Jul; 15(3):299-304. PubMed ID: 22083419
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Impact of Body Mass Index on the Quality of Life after Total Gastrectomy for Gastric Cancer.
    Park KB; Park JY; Lee SS; Kwon OK; Chung HY; Yu W
    Cancer Res Treat; 2018 Jul; 50(3):852-860. PubMed ID: 28903552
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Total Gastrectomy for CDH-1 Mutation Carriers: An Institutional Experience.
    DiBrito SR; Blair AB; Prasath V; Habibi M; Harmon JW; Duncan MD
    J Surg Res; 2020 Mar; 247():438-444. PubMed ID: 31685251
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Assessment of quality of life after gastrectomy using EORTC QLQ-C30 and STO22.
    Kobayashi D; Kodera Y; Fujiwara M; Koike M; Nakayama G; Nakao A
    World J Surg; 2011 Feb; 35(2):357-64. PubMed ID: 21104250
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Comparison of clinical efficacy and quality of life between uncut Roux-en-Y and Billroth II with Braun anastomosis in laparoscopic distal gastrectomy for gastric cancer].
    Ye XS; Lin X; Liu JJ; Shi Y; Qian F; Yu PW; Zhao YL
    Zhonghua Wei Chang Wai Ke Za Zhi; 2022 Feb; 25(2):166-172. PubMed ID: 35176829
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 8.